BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Income Quality Over TimeExpanding
Percentile Rank100
3Y CAGR+24.0%
5Y CAGR+10.7%
Year-over-Year Change
Quality of reported income
3Y CAGR
+24.0%/yr
vs -8.0%/yr prior
5Y CAGR
+10.7%/yr
Recent acceleration
Acceleration
+32.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.25 | +113.6% |
| 2024 | 0.59 | +39.4% |
| 2023 | 0.42 | -35.9% |
| 2022 | 0.65 | -15.2% |
| 2021 | 0.77 | +2.9% |
| 2020 | 0.75 | -8.8% |
| 2019 | 0.82 | -10.0% |
| 2018 | 0.91 | +46.2% |
| 2017 | 0.63 | -35.5% |
| 2016 | 0.97 | - |